SCHEMBL20236166

SCHEMBL20236166

O=C(O)N1CCN(C(=O)Nc2ccccc2)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.70
CYP2C9 P11712 2/20 0.69
CYP2C19 P33261 2/20 0.69
POLB P06746 3/20 0.67
FAAH O00519 3/20 0.66
MAPT P10636 4/20 0.64
GAA P10253 2/20 0.64
ME2 P23368 1/20 0.64
ME1 P48163 1/20 0.64
ME3 Q16798 1/20 0.64
GLA P06280 1/20 0.62
NPSR1 Q6W5P4 2/20 0.61
MEN1 O00255 1/20 0.61
HCRTR1 O43613 1/20 0.61
USP2 O75604 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
MAPK1 P28482 1/20 0.61
HTT P42858 1/20 0.61
KMT2A Q03164 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2897923 0.94 KDM4E (0.77) KDM4ECYP2C9CYP2C19POLBFAAH
SCHEMBL10729724 0.94 KDM4E (0.77) KDM4ECYP2C9CYP2C19POLBFAAH
SCHEMBL4526073 0.87 KDM4E (0.68) KDM4ECYP2C9CYP2C19POLBFAAH
SCHEMBL570715 0.86 CYP2C9 (0.71) KDM4ECYP2C9CYP2C19POLBFAAH
SCHEMBL4776281 0.86 CYP2C9 (0.71) KDM4ECYP2C9CYP2C19POLBFAAH
SCHEMBL14590550 0.85 KDM4E (0.71) KDM4ECYP2C9CYP2C19POLBFAAH
SCHEMBL4300084 0.85 KDM4E (0.93) KDM4ECYP2C9CYP2C19POLBFAAH
Hydrochloric Acid SCHEMBL7128759 0.85 POLB (0.72) KDM4ECYP2C9CYP2C19POLBFAAH
SCHEMBL4051171 0.85 RAB9A (0.69) KDM4ECYP2C9CYP2C19POLBGLA
SCHEMBL420582 0.85 RAB9A (0.69) KDM4ECYP2C9CYP2C19POLBGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3331864-B1 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2021-11-03 EP disclosed
US-10717716-B2 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2020-07-21 US disclosed
EP-3331864-A2 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2018-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10717716-B2 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same HDAC1, HDAC5, HDAC2 KDM4E 1285/4885CYP2C9 2023/4885CYP2C19 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.